Stéphane de Botton, MD is a Physician, Clinical Investigator and head of Drug Development in acute leukemias on the Department of hematology at Gustave Roussy cancer center. He conducts phase I to III clinical trials. He also belongs to the research unit UMR 1170 for novel preclinical research. He is a member of the executive board of the Acute Leukemia French Association (ALFA) that focuses on the clinical and translational research in adult acute myeloid leukemia (AML). His work has been published in journals such as The New England Journal of Medicine, Science, Nature, Nature Medicine, Journal of Clinical Oncology, JAMA Oncology, Cancer Discovery, Blood and Leukemia.
About
